[
    {
        "question": "Efficacy of new drug is confirmed in which phase?",
        "exp": "Clinical trials are divided into 4 phases: Phase I Done in healthy people - To know:- Max. tolerable dose (MTD) > Dosing >PK >Safety Phase II Done in 20-200 patients- To determine efficacy (first time) and safety Phase III Done in large no of patient upto 5000 (Multi centric)- to confirm efficacy and safety Phase IV Post marketing study - Rare/Long term side effects",
        "cop": 3,
        "opa": "Phase -1",
        "opb": "Phase-2",
        "opc": "Phase-3",
        "opd": "Phase-4",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "f051ff6f-86a7-4e76-909f-5a3f3b9c1357",
        "choice_type": "single"
    },
    {
        "question": "Which of the following statements about phase IV clinical trials is true?",
        "exp": "Phase Name Purpose I Human Pharmacology and safety To know the Maximum tolerable dose > Dose > Pharmacokinetics > Safety II Therapeutic Exploratory To establish therapeutic efficacy, dose ranging and ceiling effect III Therapeutic Confirmatory To Confirm therapeutic efficacy and To establish the value of drug in relation to existing therapy IV Post-Marketing Surveillance To know rare and long term adverse effects. Special populations like pregnancy and children can be tested 0 (ZERO) Micro-dosing studies To know pharmacokinetics Could avoid costly phase I studies for drugs with unsuitable pharmacokinetics",
        "cop": 3,
        "opa": "It is done for pediatric drugs",
        "opb": "It is done for rare drugs",
        "opc": "It is post-marketing surveillance of drugs",
        "opd": "It is also called human pharmacology and safety studies",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "fbe2751d-cb52-4bbf-8b86-d7ac759426da",
        "choice_type": "multi"
    },
    {
        "question": "Which of the following pharmacological feature is similar for both \"me-too drug\" & \"prototype drug\"?",
        "exp": "Me-too drug or Follow-on drug: A drug that is structurally very similar to already known drugs with only minor differences. It may differ with prototype drug in pharmacokinetic parameters but have similar mechanism of action and used for same conditions as the prototype drug used. Eg: Simvastatin, a me-too drug is a more effective than lovastatin, a prototype drug.",
        "cop": 1,
        "opa": "Mechanism of action",
        "opb": "Absorption",
        "opc": "Metabolism",
        "opd": "Elimination",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "58909e6d-1bc8-4f0c-92f5-bf35984632b9",
        "choice_type": "multi"
    },
    {
        "question": "Approximate number of patients recruited in phase II clinical trials of a drug are?",
        "exp": "Phase Name Conducted on I Human Pharmacology and safety Healthy Volunteers II Therapeutic Exploratory (20-200) patients III Therapeutic Confirmatory Upto 5000 patients from several centres IV Post-Marketing Surveillance Large number of patients 0 (ZERO) Microdosing studies Healthy volunteers (Small numbers)",
        "cop": 1,
        "opa": "20-100",
        "opb": "100-500",
        "opc": "500-1000",
        "opd": "1000-5000",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "fec4a944-e4ed-40fa-8a83-e4067c8bf709",
        "choice_type": "single"
    },
    {
        "question": "Healthy volunteers are recruited in which phase of clinical trials?",
        "exp": "Phase 1- Done on healthy people. Maximum tolerable dose of drug is tested Phase 2- Done on fewer patients (20-200). Efficacy and safety of drug is tested here Phase 3-Done on more patients ( upto 5000). Efficacy is confirmed in this phase Phase 4- Post marketing surveillance. Long term and rare side effects are monitored in this phase",
        "cop": 1,
        "opa": "Phase 1",
        "opb": "Phase 2",
        "opc": "Phase 3",
        "opd": "Phase 4",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "6f7a066e-7b37-4161-ad53-89c79979b8ac",
        "choice_type": "single"
    },
    {
        "question": "Comparison of efficacy of a new drug B with an existing drug A is done in which phase of clinical trials?",
        "exp": "\"The purpose of phase III trials is to obtain adequate data about the efficacy and safety of drugs in a larger number of patients of either sex in multiple centres usually in comparison with the standard drug. \" Phase I: Human Pharmacology (Non-therapeutic trials): Done in healthy persons Phase II: Therapeutic exploratory trials: conducted in patients to determine therapeutic effects, effective dose range and fuher evaluation of safety and pharmacokinetics in patients Phase III: Therapeutic confirmatory trials: Conducted to obtain adequate data about the efficacy and safety of drugs in a larger number of patients of either sex in multiple centres usually in comparison with the standard drug. Phase IV: Post marketing studies",
        "cop": 3,
        "opa": "Phase I",
        "opb": "Phase II",
        "opc": "Phase III",
        "opd": "Phase IV",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "47617f87-b6d9-4af5-ad56-89aa1d9fe7d2",
        "choice_type": "single"
    },
    {
        "question": "Major aim of phase 1 clinical trials is to know the",
        "exp": "Phase I trial is designed as a dose-escalation study to determine the maximum tolerable dosage (MTD), that is, the maximum dose associated with an acceptable level of dose-limiting toxicity. Phase 1 Clinical Trials: The drug is tested in healthy human volunteers (extremes of ages; elderly and children are excluded). As the drug is not tested in the patients, so we cannot determine efficacy in this phase. This is mainly for finding the maximum tolerable dose of the drug. This is first in human study. Because anti-cancer drugs can produce unacceptable toxicity and we cannot expose healthy humans to such a toxicity, the phase-1 trials for anticancer drugs are done in the patients",
        "cop": 3,
        "opa": "Safety",
        "opb": "Efficacy",
        "opc": "Maximum Tolerable Dose",
        "opd": "Pharmacokinetics",
        "subject_name": "Pharmacology",
        "topic_name": "CLINICAL TRIALS, DRUG LABEL",
        "id": "5c985d2c-e69f-455a-b449-1b841b442372",
        "choice_type": "single"
    }
]